article thumbnail

Low diffusing capacity for carbon monoxide in chronic thromboembolic pulmonary hypertension: a biomarker for microvascular disease?

Heart BMJ

Chronic thromboembolic pulmonary hypertension (CTEPH) is a complex pulmonary vascular disorder that involves major vessel and microvascular disease components. 1 2 Moreover, venous remodelling in occluded vascular territories due to bronchopulmonary venous shunting has been documented at the microvascular level.

article thumbnail

Case Report: Complete AV block in two patients with a congenital absence of the right coronary artery: an unusual correlation

Frontiers in Cardiovascular Medicine

No previous reports have documented the coexistence of congenital absence of the RCA and complete AV block in the same patient.Case summariesCase 1 was a 52-year-old man with no significant past medical history who experienced syncope. The prevalence of complete atrioventricular (AV) block also appears to be low.

article thumbnail

Associations of neutrophil-percentage-to-albumin ratio level with all-cause mortality and cardiovascular disease-cause mortality among patients with hypertension: evidence from NHANES 1999–2010

Frontiers in Cardiovascular Medicine

BackgroundThe associations of neutrophil-percentage-to-albumin ratio (NPAR) level with all-cause and cardiovascular disease (CVD)-cause mortality among patients with hypertension remain unclear. During 104,474 person-years of follow-up, 3,069 all-cause deaths and 1,449 CVD-cause deaths were documented. 1.23) and 1.63 (95% CI, 1.46–1.81).ConclusionsElevated

article thumbnail

Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension: A Scientific Statement From the American Heart Association

Circulation

Balloon pulmonary angioplasty continues to gain traction as a treatment option for patients with chronic thromboembolic pulmonary disease with and without pulmonary hypertension. Not surprisingly, chronic thromboembolic pulmonary hypertension centers are rapidly initiating balloon pulmonary angioplasty programs.

article thumbnail

CTA and ACC Collaborate to Tackle Cardiovascular Disease with Technology

DAIC

This new document builds off of the previously published Best Practices for Consumer Cardiovascular Technology Solutions in January 2022. The framework outlines opportunities for the broader integration of the technology into the workflow for screening and diagnosing cardiovascular disease, using AFib and Hypertension as examples.

article thumbnail

Latino–White Disparities in Identification and Control of Elevated Blood Pressure Among Adults With Hypertension

Journal of the American Heart Association

BackgroundStudies analyzing blood pressure (BP) management using the hypertension control cascade have consistently shown disparities in hypertension awareness, treatment, and BP control between Latino patients and non‐Latino White patients. Journal of the American Heart Association, Ahead of Print. 1.24]; aOR, 1.07 [95% CI, 1.02–1.12],

article thumbnail

Irbesartan and Emodin on Myocardial Remodeling in Goldblatt Hypertensive Rats

Journal of Cardiovascular Pharmacology

Objective: Interactions between the renin-angiotensin system (RAS) and transforming growth factor-beta 1 (TGF-β1) have been well documented. The aim was to explore the effect of irbesartan combining with emodin on myocardial remodeling in goldblatt (2K-1C) hypertensive rats. Correspondence to: Prof.